Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Conatus Pharmaceutic (CNAT)

8.77 +0.51 (+6.17%)

4/27/2017  4:00pm

Open:

8.36

Pre. Close:

8.26

High:

9.11

Low:

8.02

Volume:

1,555,282

Market Cap:

229.50M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

9.3 - 9.4

9.4 - 9.79

Low:

7.69 - 7.75

7.75 - 7.98

Close:

8.5 - 8.63

8.63 - 9.17

Technical analysis  (as of: 2017-04-27 4:33:16 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 10.64     One year: 12.43

Support:

Support1: 6.19    Support2: 4.38

Resistance:

Resistance1: 9.11    Resistance2: 10.64

Pivot:

7.18

Moving Averages:

MA(5): 7.95     MA(20): 6.82

MA(100): 4.86     MA(250): 3.17

MACD:

MACD(12,26): 0.79     Signal(12,26,9): 0.65

%K %D:

%K(14,3): 88.40     %D(3): 85.78

RSI:

RSI(14): 80.31

52-Week:

High: 9.11  Low: 1.45  Change(%): 205.6

Average Vol(K):

3-Month: 661  10-Days 994

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CNAT has closed above the upper band by 1.4%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 67.7% wider than normal. The large width of the bands suggest high volatility as compared to CNAT's normal range. The bands have been in this wide range for 13 bars. This is a sign that the current trend might continue.

Headline News

Thu, 27 Apr 2017 20:03:45 GMT
Conatus Pharmaceuticals to Report First Quarter 2017 Financial Results

Tue, 20 Dec 2016 14:15:00 GMT
Conatus Pharmaceuticals Inc - A Deal Emerges With Novartis As The NASH Field ...

Mon, 03 Apr 2017 13:30:00 GMT
Conatus Pharmaceuticals and MannKind Look Forward to Promoting Their Brand

Thu, 27 Apr 2017 14:48:45 GMT
Market Update: Looking at the Levels for Conatus Pharmaceuticals Inc. (NASDAQ ...

Thu, 27 Apr 2017 11:26:15 GMT
Conatus (CNAT) Catches Eye: Stock Moves Up 10% in Session

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

26.17

Shares Float (M)

23.11

% Held by Insiders

26.83

% Held by Institutions

34.40

Shares Short (K)

910

Shares Short Prior Month (K)

1040

Stock Financials

EPS

-1.310

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

0.830

PEG Ratio

-0.23

Profit Margin

Operating Margin

-3733.42

Return on Assets (ttm)

-30.5

Return on Equity (ttm)

-105.6

Qtrly Rev. Growth

Gross Profit (p.s.)

0.031

Sales Per Share

0.031

EBITDA (p.s.)

-1.136

Qtrly Earnings Growth

Operating Cash Flow (M)

27.00

Levered Free Cash Flow (M)

17.78

FoxReading.com

Valuation

P/E

-6.69

P/E Growth Ratio

0.06

P/BV

10.57

P/S

287.23

P/CF

8.50

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.